Mitsubishi UFJ Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Mitsubishi UFJ Securities’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-60	Closed	-$23K	–	64
2019 Q4	$23K	Hold	60	–	–	0.12%	58
2019 Q3	$17K	Hold	60	–	–	0.08%	67
2019 Q2	$19K	Hold	60	–	–	0.06%	186
2019 Q1	$25K	Hold	60	–	–	0.14%	109
2018 Q4	$22K	Sell	60 -100	-63%	-$36.6K	0.17%	73
2018 Q3	$65K	Hold	160	–	–	0.21%	94
2018 Q2	$55K	Buy	+160	New	+$50K	0.2%	92
2018 Q1	–	Sell	-160	Closed	-$60K	–	241
2017 Q4	$60K	Buy	160 +100	+167%	+$40.5K	0.25%	97
2017 Q3	$27K	Sell	60 -120	-67%	-$57.1K	0.13%	135
2017 Q2	$88K	Hold	180	–	–	0.47%	51
2017 Q1	$70K	Hold	180	–	–	0.38%	61
2016 Q4	$66K	Hold	180	–	–	0.37%	70
2016 Q3	$72K	Buy	180 +60	+50%	+$24.1K	0.38%	59
2016 Q2	$42K	Hold	120	–	–	0.07%	110
2016 Q1	$43K	Sell	120 -140	-54%	-$57.7K	0.06%	118
2015 Q4	$141K	Sell	260 -210	-45%	-$114K	0.21%	45
2015 Q3	$219K	Buy	470 +340	+262%	+$183K	1.55%	11
2015 Q2	$66K	Sell	130 -30	-19%	-$14.6K	0.44%	43
2015 Q1	$72K	Buy	+160	New	+$67.8K	0.19%	33
2013 Q4	–	Sell	-5,600	Closed	-$1.75M	–	20
2013 Q3	$1.75M	Buy	+5,600	New	+$1.47M	0.74%	27

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Mitsubishi UFJ Securities's REGN Position: Q1 2020 in Review

Mitsubishi UFJ Securities sold out of Regeneron Pharmaceuticals (REGN) in Q1 2020, closing a stake of 60 shares — an estimated $23K sold.

Mitsubishi UFJ Securities first reported a position in REGN in Q3 2013 and held it in 20 quarters. The position peaked at $1.75M in Q3 2013. 816 funds tracked by Wall St. Rank hold REGN as of Q1 2020.

Mitsubishi UFJ Securities reported no remaining Regeneron Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Mitsubishi UFJ Securities sold 60 Regeneron Pharmaceuticals shares in Q1 2020, an estimated $23K.
Mitsubishi UFJ Securities first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 20 quarters.
Mitsubishi UFJ Securities's Regeneron Pharmaceuticals position peaked at $1.75M in Q3 2013.
816 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2020.

Based on Mitsubishi UFJ Securities's 13F filing for Q1 2020, filed 13 May 2020.